ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Update

ProtoKinetix, Incorporated (OTCMKTS:PKTX) was the recipient of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 10,500 shares, an increase of 2,525.0% from the February 13th total of 400 shares. Based on an average trading volume of 414,700 shares, the short-interest ratio is currently 0.0 days.

ProtoKinetix Price Performance

PKTX traded down $0.00 on Wednesday, reaching $0.01. The stock had a trading volume of 56,312 shares, compared to its average volume of 168,423. ProtoKinetix has a fifty-two week low of $0.01 and a fifty-two week high of $0.02. The firm has a 50-day moving average of $0.01 and a 200-day moving average of $0.01.

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.